Skip to content

HVNI vs CPAP in Children With Acute Respiratory Distress

Assessment of Outcome and Tolerability of High Velocity Nasal Insufflation and Continuous Positive Airway Pressure in Children With Acute Respiratory Distress

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07336121
Acronym
P-HVNI-CPAP
Enrollment
80
Registered
2026-01-13
Start date
2023-01-09
Completion date
2024-12-01
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Community Acquired Pneumonia, Bronchiolitis

Keywords

High -Velocity Nasal Insufflation, Continuous positive Airway Pressure, Pediatric Acute Respiratory Distress, pediatric intensive care unit

Brief summary

Acute breathing problems are a common reason for children to be admitted to the pediatric intensive care unit, and many of these children need breathing support without a breathing tube. High-Velocity Nasal Insufflation (HVNI) and nasal Continuous Positive Airway Pressure (nCPAP) are commonly used to help children breathe, but there is limited information comparing how well they work and how comfortable they are for children. This study aims to compare the clinical outcomes and tolerability of HVNI and nCPAP in children aged 1 month to 5 years with acute respiratory distress admitted to the pediatric intensive care unit, using clinical assessment and lung ultrasound findings.

Detailed description

Acute respiratory distress represents a major cause of morbidity and mortality in infants and young children and accounts for a significant proportion of pediatric intensive care unit admissions. A considerable number of affected children fail conventional low-flow oxygen therapy and require escalation to non-invasive respiratory support. High Velocity Nasal Insufflation delivers heated and humidified oxygen at high flow rates through nasal cannulae and may improve oxygenation by washing out nasopharyngeal dead space, reducing inspiratory resistance, and providing a degree of positive end-expiratory pressure. Nasal Continuous Positive Airway Pressure delivers a continuous distending airway pressure with supplemental oxygen, improving lung recruitment, reducing atelectasis, and enhancing ventilation-perfusion matching. Both modalities are commonly used in pediatric intensive care practice; however, evidence comparing their clinical effectiveness, tolerability, and impact on lung aeration in young children remains inconclusive. Lung ultrasound has emerged as a reliable, non-invasive bedside tool for assessment of lung aeration and disease severity in critically ill children. This prospective interventional study will enroll 80 children aged 1 month to 5 years admitted to the pediatric intensive care unit with acute respiratory distress who have failed low-flow oxygen therapy. Patients will be randomized into two groups: one group receiving High Velocity Nasal Insufflation and the other receiving nasal Continuous Positive Airway Pressure. All patients will undergo daily clinical assessment and lung ultrasound scoring during their pediatric intensive care unit (PICU) stay. Tolerability will be evaluated using the FLACC (Face, Legs, Activity, Cry, Consolability) pain scale. The primary outcome is improvement in lung aeration as assessed by lung ultrasound score. Secondary outcomes include assessment of clinical response to therapy based on respiratory rate, oxygen saturation (SpO₂), and need for escalation of respiratory support . The results of this study aim to provide evidence to guide selection of optimal non-invasive respiratory support in children with acute respiratory distress.

Interventions

High Velocity Nasal Insufflation will be delivered using a heated, humidified nasal cannula system to children aged 1 month to 5 years with acute respiratory distress who failed low-flow oxygen therapy. Therapy will be initiated and adjusted according to clinical condition and institutional PICU protocol. Patients will be monitored clinically and by daily lung ultrasound score during PICU stay.

DEVICENasal Continuous Positive Airway Pressure (Nasal CPAP)

Nasal Continuous Positive Airway Pressure will be delivered via nasal interface providing continuous positive airway pressure with supplemental oxygen to children aged 1 month to 5 years with acute respiratory distress who failed low-flow oxygen therapy. Settings will be adjusted according to clinical response and institutional PICU protocol. Patients will be monitored clinically and by daily lung ultrasound score during PICU stay.

Sponsors

Ain Shams University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
1 Months to 5 Years
Healthy volunteers
No

Inclusion criteria

* Children aged 1 month to 5 years * Admitted to the Pediatric Intensive Care Unit (PICU) * Diagnosed with acute respiratory distress * Failure of low-flow nasal oxygen therapy * Requiring non-invasive respiratory support * Informed consent obtained from parent or legal guardian

Exclusion criteria

* Presence of congenital or acquired cardiac disease * Neuromuscular disorders * Chronic lung disease * History of recurrent wheezing * History of cardio-respiratory arrest * Presence of significant comorbid chronic illness * Contraindication to non-invasive ventilation

Design outcomes

Primary

MeasureTime frameDescription
Improvement in lung aeration assessed by lung ultrasound scoreAt Baseline, pre procedural , 48 hours .To compare the effectiveness of High Velocity Nasal Insufflation versus Nasal Continuous Positive Airway Pressure in improving lung aeration in children with acute respiratory distress, assessed by daily lung ultrasound score during PICU stay. The LUS ranges from 0 to 36, where higher scores indicate worse lung aeration and lower scores indicate improvement.

Secondary

MeasureTime frameDescription
Clinical improvement of respiratory distress assessed by Modified Respiratory Distress ScoreBaseline and 48 hours after initiation of respiratory supportClinical improvement assessed using a Modified Respiratory Distress Score(MRDS), which incorporates respiratory rate (breaths/min), oxygen saturation measured by pulse oximetry (SpO₂, %), and fraction of inspired oxygen (FiO₂, %). The MRDS ranges from 0 to 12, where higher scores indicate more severe respiratory distress and lower scores indicate clinical improvement.

Countries

Egypt

Contacts

PRINCIPAL_INVESTIGATORTarek A. Abdelgawad, MD

Ain Shams University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026